Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cooper Companies (COO) Asset Utilization Ratio (2010 - 2026)

Cooper Companies' quarterly Asset Utilization Ratio came in at 0.33 in Q1 2026, up 4.48% year-on-year from 0.32 in Q1 2025, and up 1.26% quarter-over-quarter from 0.33 in Q4 2025.

Cooper Companies has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.33 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 4.48% year-over-year to 0.33; the trailing twelve-month figure through Jan 2026 stood at 0.33 (up 4.48% YoY), and the FY2025 full-year result was 0.33, up 1.93% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.33, up from 0.33 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.33 in Q1 2026, with the low at 0.27 in Q2 2022.
  • Average Asset Utilization Ratio over 5 years is 0.31, with a median of 0.31 recorded in 2024.
  • Year-over-year, Asset Utilization Ratio slipped 9.68% in 2022 and grew 10.78% in 2023.
  • Tracing COO's Asset Utilization Ratio over 5 years: stood at 0.29 in 2022, then grew by 7.16% to 0.31 in 2023, then grew by 3.67% to 0.32 in 2024, then advanced by 3.58% to 0.33 in 2025, then advanced by 1.26% to 0.33 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.33 (Q1 2026), 0.33 (Q4 2025), and 0.33 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.52
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.40
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.64
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.77
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.58
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.33
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.65
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.54
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.75
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn 0.26

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 0.33
Oct 31, 2025 0.33
Jul 31, 2025 0.33
Apr 30, 2025 0.32
Jan 31, 2025 0.32
Oct 31, 2024 0.32
Jul 31, 2024 0.31
Apr 30, 2024 0.31
Jan 31, 2024 0.31
Oct 31, 2023 0.31
Jul 31, 2023 0.30
Apr 30, 2023 0.30
Jan 31, 2023 0.29
Oct 31, 2022 0.29
Jul 31, 2022 0.28
Apr 30, 2022 0.27
Jan 31, 2022 0.28
Oct 31, 2021 0.30
Jul 31, 2021 0.31
Apr 30, 2021 0.30
Jan 31, 2021 0.31
Oct 31, 2020 0.36
Jul 31, 2020 0.37
Apr 30, 2020 0.39
Jan 31, 2020 0.42
Oct 31, 2019 0.43
Jul 31, 2019 0.42
Apr 30, 2019 0.41
Jan 31, 2019 0.41
Oct 31, 2018 0.41
Jul 31, 2018 0.39
Apr 30, 2018 0.37
Jan 31, 2018 0.40
Oct 31, 2017 0.44
Jul 31, 2017 0.44
Apr 30, 2017 0.44
Jan 31, 2017 0.44
Oct 31, 2016 0.43
Jul 31, 2016 0.41
Apr 30, 2016 0.41
Jan 31, 2016 0.41
Oct 31, 2015 0.40
Jul 31, 2015 0.41
Apr 30, 2015 0.41
Jan 31, 2015 0.40
Oct 31, 2014 0.44
Jul 31, 2014 0.50
Apr 30, 2014 0.52
Jan 31, 2014 0.52
Oct 31, 2013 0.52
Jul 31, 2013 0.53
Apr 30, 2013 0.52
Jan 31, 2013 0.51
Oct 31, 2012 0.50
Jul 31, 2012 0.51
Apr 30, 2012 0.53
Jan 31, 2012 0.52
Oct 31, 2011 0.51
Jul 31, 2011 0.49
Apr 30, 2011 0.47
Jan 31, 2011 0.47
Oct 31, 2010 0.46